Rheumatoid arthritis (RA) is a chronic inflammatory disease, presenting with joint inflammation and its progressive destruction, affecting a range of about 0.24–1% of the population in different parts of the world. It is one of the major disabling conditions among middle-aged and older women. In this study, the association between five single nucleotide polymorphisms (SNPs) of the CTLA4 gene and RA was investigated.
Materials and Methods:
The study group included 200 patients with RA and 184 healthy individuals from the Iranian population as a control group. Results: After PCR and genotyping, 4 of the 5 SNPs studied showed a significant association with RA. Also, an association between specific haplotypes with RA was determined.
Conclusion:
Based on the results, it can be said that some SNPs of the CTLA4 gene may serve as genetic markers for predicting RA susceptibility or progression and using personalized treatment, lead to improved outcomes among patients with RA.
Get full access to this article
View all access options for this article.
References
1.
AletahaD, NeogiT, SilmanAJ, et al.2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum, 2010; 62(9):2569–2581.
2.
BoagAM, ShortA, KennedyLJ, et al.Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism. Canine Med Genet, 2020; 7:2–13.
3.
CaiG-M, GaoZ, YueY-X, et al.Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort. J Clin Neurosci, 2019; 69:31–37.
4.
ChenD-P, ChangS-W, WangP-N, et al.The association between single-nucleotide polymorphisms of co-stimulatory genes within non-HLA region and the prognosis of leukemia patients with hematopoietic stem cell transplantation. Front Immunol, 2021; 12:730507.
5.
ChenD-P, ChuY-C, WenY-H, et al.Investigation of the correlation between graves’ ophthalmopathy and CTLA4 gene polymorphism. J Clin Med, 2019; 8(11):1842.
6.
ChenD-P, WenY-H, LinW-T, et al.Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis. Front Immunol, 2023; 14:1123832.
7.
ConfortiA, Di ColaI, PavlychV, et al.Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity Reviews, 2021; 20(2):102735.
8.
CrossM, SmithE, HoyD, et al.The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis, 2014; 73(7):1316–1322.
9.
FernÂndez-MestreM, SÂnchezK, BalbÂsO, et al.Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum Immunol, 2009; 70(7):532–535.
10.
GabrielSB, SchaffnerSF, NguyenH, et al.The structure of haplotype blocks in the human genome. Science, 2002; 296(5576):2225–2229.
11.
GhaderiA. CTLA4 gene variants in autoimmunity and cancer: A comparative review. Iranian J Immunol, 2011; 8(3):127–149.
IaremenkoO, MykytenkoG. Achievement of clinical remission in patients with rheumatoid arthritis depending on the ACCP-and RF-serological status. Georgian Med News, 2021(318):99–104.
14.
JamshidiA-R, BanihashemiAT, RoknsharifiS, et al.Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: A WHO-ILAR COPCORD Study (from Iran COPCORD study, Urban Study stage 1). Medical Journal of the Islamic Republic Of Iran, 2014; 28:93.
15.
KasamatsuT, InoR, TakahashiN, et al.PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia. Br J Haematol, 2018; 180(5):705–714.
16.
KomarAA. Single nucleotide polymorphisms. Methods in Molecular Biology, 2009; 578(10):978.
17.
LiX, ZhangC, ZhangJ, et al.Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: A meta-analysis. J Clin Immunol, 2012; 32(3):530–539.
18.
LiuJ, ZhangH. −1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): A comprehensive meta-analysis. Hum Immunol, 2013; 74(3):341–347.
19.
LiuW, YangZ, ChenY, et al.The association between CTLA-4, CD80/86, and CD28 gene polymorphisms and rheumatoid arthritis: An original study and meta-analysis. Frontiers in Medicine, 2021; 8:598076.
20.
MehrabiN, LangarizadehM, AhmadzadehA. Challenges of Rheumatoid Arthritis Registry in Iran: Qualitative Content Analysis. Crescent Journal of Medical & Biological Sciences, 2019; 6(4).
21.
MousaviMJ, ShayestehMRH, JamalzehiS, et al.Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis. J Res Med Sci, 2021; 26(1):22.
22.
MukhtarM, SheikhN, SuqainaSK, et al.Genetic susceptibility of cytotoxic T lymphocyte-associated antigen 4 gene polymorphism in the onset of arthritis. medRxiv, 2021.
23.
NakkenB, PappG, BosnesV, et al.Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives. Immunol Lett, 2017; 189:13–18.
24.
RobertF, PelletierJ. Exploring the impact of single-nucleotide polymorphisms on translation. Front Genet, 2018; 9:507.
25.
SchorkNJ, FallinD, LanchburyJS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet, 2000; 58(4):250–264.
26.
SokkaT, PincusT. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%–45% of patients with rheumatoid arthritis seen between 1980 and 2004: Analyses from Finland and the United States. J Rheumatol, 2009; 36(7):1387–1390.
27.
Van DrongelenV, HoloshitzJ. Human leukocyte antigen–disease associations in rheumatoid arthritis. Rheumatic Disease Clinics, 2017; 43(3):363–376.
28.
ZhouC, GaoS, YuanX, et al.Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: A meta-analysis. Aging (Albany NY), 2021; 13(15):19397–19414.
